41872 Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices 

Public Availability of Comments 

Before including your address, phone 

number, email address, or other 

personal identifying information in your 

comment, you should be aware that 

your entire comment—including your 

personal identifying information—may 

be made publicly available at any time. 

While you can ask us in your comment 

to withhold your personal identifying 

information from public review, we 

cannot guarantee that we will be able to 

do so. 

Authority 

The authority for this action is section 

4(f) of the Endangered Species Act of 

1973, as amended (16 U.S.C. 1531 et 

seq.). 

Robyn Thorson, 

Regional Director, U.S. Fish and Wildlife 

Service. 

[FR Doc. 2021–16521 Filed 8–2–21; 8:45 am] 

BILLING CODE 4333–15–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–874] 

Bulk Manufacturer of Controlled 

Substances Application: Purisys, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Purisys, LLC has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 4, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

October 4, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on June 30, 2021, 1550 

Olympic Drive, Athens, Georgia 30601– 

1602, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled 

substance Drug code Schedule 

Opium, powdered.9639 II 

Opium, granulated.9640 II 

The company plans to bulk 

manufacture the listed controlled 

substances as Active Pharmaceutical 

Ingredient (API) for distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–16500 Filed 8–2–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–873] 

Bulk Manufacturer of Controlled 

Substances Application: Cerilliant 

Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cerilliant Corporation has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTAL INFORMATION listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 4, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

October 4, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on June, 24, 2021, 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................. 1238 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... 6250 I 

SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................. 7008 I 

ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................. 7011 I 

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................... 7012 I 

FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ............................................... 7014 I 

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7019 I 

MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ....................... 7020 I 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices 41873 

Controlled substance Drug code Schedule 

FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 

methylbutanoate).

7021 I 

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .......................................... 7023 I 

THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 7024 I 

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ......................... 7025 I 

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................ 7031 I 

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......... 7032 I 

5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ............................................... 7033 I 

5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........ 7034 I 

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. 7035 I 

5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........................... 7036 I 

5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ................................ 7041 I 

MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate).

7042 I 

MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ......... 7044 I 

FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide).7047 I 

APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................ 7048 I 

5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................... 7049 I 

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... 7081 I 

5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ...................... 7083 I 

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ................. 7085 I 

4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1- 

(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).

7089 I 

SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ..................................................................... 7104 I 

JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... 7122 I 

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. 7144 I 

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ 7173 I 

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I 

NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate .......................................................... 7221 I 

PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................. 7222 I 

5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................. 7225 I 

4-MEAP (4-Methyl-alpha-ethylaminopentiophenone) ...................................................................................................... 7245 I 

N-Ethylhexedrone ............................................................................................................................................................ 7246 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. 7297 I 

CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... 7298 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ................................................................................................. 7348 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ............................................................................................ 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

4′-Chloro-alpha-pyrrolidinovalerophenone ....................................................................................................................... 7443 I 

MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ........................................................................................................... 7446 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 


jbell on DSKJLSW7X2PROD with NOTICES
41874 Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices 

Controlled substance Drug code Schedule 

4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 7498 I 

2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 7508 I 

2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ...................................................................................................... 7509 I 

2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) ................................................................................................................... 7517 I 

2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .......................................................................................................... 7518 I 

2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .................................................................................................... 7519 I 

2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ..................................................................................................... 7521 I 

2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .............................................................................................. 7524 I 

2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ..................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 7536 I 

25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 7537 I 

25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ..................................................... 7543 I 

a-PHP, alpha-Pyrrolidinohexanophenone ....................................................................................................................... 7544 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I 

Ethylone ........................................................................................................................................................................... 7547 I 

PV8, alpha-Pyrrolidinoheptaphenone .............................................................................................................................. 7548 I 

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... 7694 I 

Acetyldihydrocodeine ....................................................................................................................................................... 9051 I 

Benzylmorphine ............................................................................................................................................................... 9052 I 

Codeine-N-oxide .............................................................................................................................................................. 9053 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Brorphine ......................................................................................................................................................................... 9098 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Heroin .............................................................................................................................................................................. 9200 I 

Hydromorphinol ............................................................................................................................................................... 9301 I 

Methyldesorphine ............................................................................................................................................................ 9302 I 

Methyldihydromorphine ................................................................................................................................................... 9304 I 

Morphine methylbromide ................................................................................................................................................. 9305 I 

Morphine methylsulfonate ............................................................................................................................................... 9306 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................... 9547 I 

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ................................................................................................... 9560 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Isotonitazene ................................................................................................................................................................... 9614 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Trimeperidine ................................................................................................................................................................... 9646 I 

Phenomorphan ................................................................................................................................................................ 9647 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................... 9816 I 

Para-Methylfentanyl ......................................................................................................................................................... 9817 I 

4′-Methyl Acetyl Fentanyl ................................................................................................................................................ 9819 I 

Ortho-Methyl Methoxyacetyl Fentanyl ............................................................................................................................. 9820 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

Butyryl Fentanyl ............................................................................................................................................................... 9822 I 

Para-fluorobutyryl fentanyl ............................................................................................................................................... 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices 41875 

Controlled substance Drug code Schedule 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... 9825 I 

Para-chloroisobutyryl fentanyl ......................................................................................................................................... 9826 I 

Isobutyryl fentanyl ............................................................................................................................................................ 9827 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ................................................................................................................................................. 9836 I 

Para-methoxybutyryl fentanyl .......................................................................................................................................... 9837 I 

Ocfentanil ......................................................................................................................................................................... 9838 I 

Thiofuranyl Fentanyl ........................................................................................................................................................ 9839 I 

Valeryl fentanyl ................................................................................................................................................................ 9840 I 

Phenyl Fentanyl ............................................................................................................................................................... 9841 I 

Beta′-Phenyl Fentanyl ..................................................................................................................................................... 9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................... 9843 I 

Crotonyl Fentanyl ............................................................................................................................................................ 9844 I 

Cyclopropyl Fentanyl ....................................................................................................................................................... 9845 I 

Ortho-Fluorobutyryl Fenanyl ............................................................................................................................................ 9846 I 

Cyclopentyl fentanyl ........................................................................................................................................................ 9847 I 

Ortho-Methyl Acetylfentanyl ............................................................................................................................................ 9848 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... 9850 I 

Fentanyl Carbamate ........................................................................................................................................................ 9851 I 

Ortho-Fluoroacryl Fentanyl .............................................................................................................................................. 9852 I 

Ortho-Fluoroisobutyryl Fentanyl ...................................................................................................................................... 9853 I 

Para-Fluoro Furanyl Fentanyl .......................................................................................................................................... 9854 I 

2′-Fluoro Ortho-Fluorofentanyl ........................................................................................................................................ 9855 I 

Beta-Methyl Fentanyl ....................................................................................................................................................... 9856 I 

8Amphetamine ................................................................................................................................................................. 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Phenmetrazine ................................................................................................................................................................. 1631 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ..................................................................................................................... 8333 II 

Norfentanyl ...................................................................................................................................................................... 8366 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Metazocine ...................................................................................................................................................................... 9240 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Alfentanil .......................................................................................................................................................................... 9737 II 


jbell on DSKJLSW7X2PROD with NOTICES
41876 Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices 

Controlled substance Drug code Schedule 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates or for sale to its 

customers. In reference to dug codes 

7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–16499 Filed 8–2–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act 

On July 23, 2021, the United States 

lodged a proposed consent decree with 

the United States District Court for the 

Northern District of Illinois in the 

lawsuit entitled United States v. Chains 

and Links, Inc. et al., Case No. 3:18–cv– 

50268 (N.D. Ill.). The proposed consent 

decree, if approved by the Court after 

public comment, will fully resolve 

claims of the United States 

Environmental Protection Agency 

(‘‘EPA’’) against the two remaining 

defendants named in the complaint, 

which seeks to recover response costs 

incurred by EPA in cleaning up a 

portion of the Bautsch Gray Mine 

Superfund site (‘‘Site’’) near Galena, 

Illinois. Under a prior consent decree, 

which was approved by the Court in 

May, EPA will recover $1.292 million in 

response costs over an 18-month period. 

Under the proposed consent decree, the 

settling defendants—West Galena 

Development, Inc. (‘‘WGD’’) and the 

Estate of Lois Jean Wienen (‘‘Estate’’)— 

will reimburse the United States for 

$1.25 million in response costs, bringing 

our total recovery in this action to 

$2.542 million. 

The United States brought this action 

in 2016 asserting claims under Sections 

106, 107, and 113(g)(2) of the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act (‘‘CERCLA’’), 42 U.S.C. 9606, 

9607(a), and 9613(g)(2). To resolves 

these claims, WGD and the Estate will 

not only reimburse the United States for 

response costs, but also undertake 

limited activities with respect to a 

portion of the Site that is jointly owned 

by WGD and one of the prior settling 

defendants. WGD and the Estate, for 

instance, must provide EPA and its 

contractors with access to the property 

and must cooperate with the priorsettling defendants in executing an 

environmental covenant that will give 

EPA enforcement rights relating to the 

property. If the property is sold in the 

future at a price that reflects the value 

of the property after it has been cleaned 

up in accordance with the EPA-selected 

remedy for the Site, EPA will receive 

75% of the net proceeds from the sale. 

Finally, the proposed consent decree 

resolves a counterclaim asserted by 

WGD for breach of contract and relief 

under the Administrative Procedures 

Act. 

The publication of this notice opens 

a period for public comment on the 

proposed consent decree. Comments 

should be addressed to the Acting 

Assistant Attorney General, 

Environment and Natural Resources 

Division, and should refer to United 

States v. Chains and Links, Inc. et al., 

D.J. Ref. No. 90–11–3–10235. All 

comments must be submitted no later 

than thirty (30) days after the 

publication date of this revised notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ......... pubcomment-ees.enrd@

usdoj.gov. 

By mail ........... Acting Assistant Attorney 

General, U.S. DOJ— 

ENRD, P.O. Box 7611, 

Washington, DC 20044– 

7611. 

During the public comment period, 

the proposed consent decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

We will also provide a paper copy of the 

proposed consent decree upon written 

request and payment of reproduction 

costs. Please mail your request and 

payment to: Consent Decree Library, 

U.S. DOJ—ENRD, P.O. Box 7611, 

Washington, DC 20044–7611. 

Please enclose a check or money order 

for $17.25 (69 pages at 25 cents per page 

reproduction cost) payable to the United 

States Treasury. For a paper copy 

without the appendices and signature 

pages, the cost is $8. 

Patricia McKenna, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2021–16520 Filed 8–2–21; 8:45 am] 

BILLING CODE 4410–15–P 

NEIGHBORHOOD REINVESTMENT 

CORPORATION 

Sunshine Act Meetings; Audit 

Committee Meeting 

TIME AND DATE: 3:00 p.m., Wednesday, 

August 11, 2021. 

PLACE: Via Conference Call. 

STATUS: Parts of this meeting will be 

open to the public. The rest of the 

meeting will be closed to the public. 

MATTERS TO BE CONSIDERED: Audit 

Committee Meeting. 

The General Counsel of the 

Corporation has certified that in his 

opinion, one or more of the exemptions 

set forth in the Government in the 

Sunshine Act, 5 U.S.C. 552b (c)(2) and 

(4) permit closure of the following 

portion(s) of this meeting: 

• Executive Session 

Agenda 

I. Call to Order 

II. Executive Session with Chief Audit 

Executive 

III. Action Item Request to Cancel 

Internal Audit Project: Tipalti-Third 

Party Vendor Contract 

IV. Discussion Item Tracking Open 

Recommendations 

a. Dependent on Other IT Projects 

b. Monitoring Identity Access 

Management (IAM) Development 

i. ITS Audit and Security Roadmap 

V. Discussion Item Internal Audit Status 

Reports 

a. Internal Audit Reports Awaiting 

Managements Response 

D HPN Launchpad 

D Application and Systems Change 

Management 


jbell on DSKJLSW7X2PROD with NOTICES